Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Like many others who don't post at all, or post infrequently, I am always grateful for the insights here.
I know Scancell have been doing the right things for a long time and that many will benefit from the dedication and determination to find great solutions. I am satisfied and absolutely happy to pick up extra shares when I can.
I am looking forward to the next AGM because much more will be certain, and I'm sure that Scancell are making plans to capitalise on their success.
I hope all enjoy this great weekend, whatever you are doing.
It would not hurt to push scancells name with the article on networks
Ideas
Was that under the company name or the LSE code?
Could we ask search wikp d scancell and then report info missing?
Violin, How do you see a USA listing working. Because of the need to save for retirement there many opt for investments, so like publishing in American, there could be many more PIs, and of course, family offices looking to boost their numbers.
Anyone else feel we usually get a lift on a Friday?
It can't just be the £ dropping, could it?
If we head to parity, then Scancell's share should in theory raise to over 20p (taking a liberal view of their highest price and the exchange rate at that time).
What's the latest on a USA listing, and do you think shareholders will be given an opportunity to buy in at advantageous rates?
Those who contribute here are valued. They have worked long hours, have things to do besides, and this BB is not their day job.
I find reading back posts informative as often it is this time of the week before I have tome to catch up again. There is plenty elsewhere to catch up upon.
Thanks to all for the positive contributions. For those new to the board, perhaps scroll though the headlines for more interesting posts than the "when moon" posts (eg when news, ditto, ditto, ditto)
If anyone has time to cross-reference that great posts here, I'd be willing to buy you a coffee should you want to come to my neck of the woods.
Iofas, I have not kept up with recent news, but originally there were nit enough unvaccinated to run a trial in the UK, and CT1, part 2 was targeted as a booster jab.
I would be happy to volunteer for scancells jab as someone who has to date not had covid.
For those interested in variants, https://twitter.com/kayakkim11/status/1543419204166098944
And my hope is that Scancell ticks all their boxes and is also effective for the immunosurpressed!
The joys of a phone keyboard ??
*there are in forster line.
Can't bear to look for other autocorrect and typos ....
Off topic" First time ever in my life I was on a sea scooter this afternoon. Absolutely great fun and I am now looking for the best places around Scotland to explore with one. Hope everyone managed to fit in some fun the weekend, summer solstice has come and gone :)
My view is not worth a lot here, but there a 180k we know about who succumbed to Covid. Those who are immunsurpressed are ignored altogether in the UK.
I'm not sure if I ever saw whether the targeting of dentritic cells means that Scancell's Covidity vaccine will be a global lifeline for all those around the globe who have no effective vaccine.
My hope is that having worked for decades with thise who are immunsurpressed, led to Scabcell taking a much better path which benefits everyone.
Lack of effective media handling not withstanding, even a proactive session would be something useful to have outdoor public consumption.
In the meantime, I will pick up what I can whilst the share remains ignored by private and institutional investors alike.
All the best everyone, LL
BURBLE, Thanks for this.
21 likes as of now, which is more than I can recall seeing for some time - makes me think I should be sharing the link for this board to help grow the number of those in the know.
This is indeed an exciting time for new solutions, and whilst few firms have 1st claimer advantage (which helps their financial success), I'm quite content knowing that there are others also doing essential research and making major breakthroughs.
I hope all have been enjoying the day, whatever you have been doing with your time.
Burble, thanks for looking into the immunosurpressed immunity situation. There are many who are in this situation. From what little I have been able to find the dentritic cells are not usually targeted by the medications being used to treat serious medical conditions.
Understand the pressures of work. I'd best get back to mine...
Hope you don't mind a daft lassie question about covidity.
Currently many who are immunsurpressed don't benefit from the mRNA vaccines in the way that everyone else does.
Does Scancells covidity vaccine provide some hope? - eg as the dentritic cells it targets are not the ones which are most affected by medical treatment.
Tweets are out now. I search for Scancell and then have to correct Twitter's assumption for Scanell..
Trinity Delta seem to be saying their valuation is around 30p all in.
https://app.researchpool.com/provider/trinity-delta/scancell-holdings-sclp-trinity-delta-lighthouse-scancell-7iNy0C8Kz8?utm_source=dlvr.it&utm_medium=twitter
Trinity Delta Lighthouse: Scancell
Trinity Delta view: The first-in-human trial of Scancell’s Modi-1 vaccine is a key step that could provide important information on the safety and immunogenicity of this novel approach, with the latter providing valuable early indications of potential efficacy. Assuming a smooth roll-out to the other study centres and no recruitment issues, early safety and immunogenicity data should be available by H222, and early efficacy results during 2023. Scancell has four novel inter-related technology platforms: ImmunoBody, Moditope, Glymabs, and AvidiMab. The ImmunoBody and Moditope oncology vaccines offer different approaches to treat intractable cancers both as monotherapy and in combination with agents such as CPIs. We value Scancell using an rNPV model and the Moditope programme is the largest contributor to our 29.1p/share (24.2p fully diluted) valuation, accounting for 11.9p (9.9p fully diluted). Successful clinical outcomes with Modi-1 would validate the Moditope platform and would lead, in our view, to material upside.
I agree, good stuff happening.
I did my bed and Isa a few weeks ago. I am looking forward to thise tax free gains eventually!
Covid during pregnancy doubled babies’ risk of delayed development in speech, motor skills
This crossed my covid feed - apologies if it has already been discussed witht he need for better covid vaccines.
https://www.scmp.com/news/world/united-states-canada/article/3181102/covid-during-pregnancy-doubled-babies-risk-delayed
Hi all, I just want to thank everyone for their contributions- it was great to wake up to such a stimulating discussion which has expanded my knowledge considerably in a very easily understandable way.
Time to get out for a walk - it's taking longer than I expected for the ankle to heal, so it won't be far or quick. I have found going slower gives more time to appreciate more things.
Finding joy in the day, LL
JB, and everyone else,
Thanks for following up on this.
I got a random US Biotech investor type connection on one of the social media channels so I could not resist mentioning Scancell. With the drop in the £, Scancell looking like a bargain!